L1-79

· Yamo Pharmaceuticals LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for L1-79, covering 2024-07-31 to 2024-08-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety of L1-79 in Adolescent and Adult Males With Autism [Phase 2]